2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.55-$0.03 (-0.73%)
Price as of Oct 22, 2026 8:00 PM EDT- $1.9BMarket Cap
- -36.70%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.55-$0.03 (-0.73%)
Earnings Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 31.49% | ||
12-Month Momentum | -33.72% | ||
3-Month Risk Adjusted Momentum | 104.53% | ||
12-Month Risk Adjusted Momentum | -52.31% |
True Yield
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.01% | ||
Net Debt Paydown Yield | 0.11% |
Financial Health Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |